Andrew Left’s conviction for securities fraud does more than punish a short seller. This forces one to reread a decade of stories in which the recipients of short campaigns were assumed to be bad guys and the people writing the campaigns were assumed to be truth tellers. The case of Barry Honig provides a useful test of this hypothesis.
Start with what is not in dispute. Honig is an active early-stage and microcap financier – someone who invested capital in very small companies that couldn’t raise it through conventional channels, took large positions early on, and helped build several of them. This is a real and legitimate function in small-cap markets, and the results are real. He was an early backer of Interclick, the ad technology company acquired by Yahoo for about $270 million in 2011; served as co-chairman of ChromaDex, now Niagen Bioscience (Nasdaq: NAGE); and was an early investor in companies that pivoted to bitcoin mining – the companies that became Riot Platforms and MARA Holdings, with market values of approximately $9 billion and $4.9 billion, respectively, as of May 2026. Critics of companies once labeled worthless have not behaved like worthless companies.
Its defenders put forward a simple argument that deserves to be heard. The tools Honig uses – discounted private placements, convertible structures, large controlling stakes – are ordinary microcapitalization mechanisms, and are not in themselves evidence of a scheme. They argue that the SEC’s theory has taken routine financing and turned it into manipulation, and that the agency’s rules on beneficial ownership and “acting as a group” are technical enough that a loose network of co-investors can be swept up into a single “control group” narrative that overestimates the degree of coordination of each. Reasonable securities lawyers disagree on the exact position of this limit. This is a real live debate, not a settled issue.
Honesty requires clearly stating the other half. In 2018, the SEC accused Honig of being the alleged mastermind of pump-and-dump schemes at three microcap companies, and in 2019, he settled the matter – agreeing to a ban on investing in penny stocks, without admitting or denying the allegations. This is not a justification, and its defenders do it no favors by calling it such. This is a civil resolution in which he never admitted any wrongdoing and the case never challenged his conduct at trial.
Where his conduct has been tested, the result is more revealing. In litigation brought by biotech company MabVax, its former chief executive has sworn that four specific statements in a 2015 article were materially false — the heart of a “pump and dump” claim against Honig. Under cross-examination, it turned out that these four statements had been taken almost verbatim from an investor presentation that the same executive had created and delivered himself, weeks before the article appeared.
This is the kind of fact that really moves a reputation forward, because it’s specific, documented, and stands up to scrutiny. This does not prove that Honig was right about everything, and it should not be stretched. It proves something more precise and stronger: that at least one highly repeated fraud allegation against him collapsed the moment it encountered the evidence — which is precisely the pattern that the left’s verdict suggests is worth taking seriously rather than dismissing.
None of this requires believing that every short seller is a criminal or that Honig is beyond criticism. It simply requires what the last decade has often denied it: the presumption that the story told about a man is not the same thing as the truth about him, and that the person writing the story might have a position to protect. After Citron, this presumption is finally a reasonable starting point.
Supply : SEC v. Honig (SDNY, 2018 charges; 2019 settlement and penny-stock bar); MabVax Litigation File and Transcript of Cross-Examination (via attorney Sheppard Mullin); Public registers of mergers and acquisitions and companies; Bloomberg (Left-wing verdict). The argument between financing and manipulation is presented as the argument of Honig and his defenders.
